Real-life Evaluation of the Daivobet® Gel Applicator (ASAP PSO)

LEO Pharma

Status: Completed

Conditions: Plaque Psoriasis

Treatments: Drug: calcipotriol/betamethasone dipropionate gel in Applicator

Study type: Observational

Funder types: Industry

Identifiers

NCT02856542

NIS-DAIVOBETGEL-1284

Details and patient eligibility

About

This study aims to describe the patient population being treated and evaluate their treatment adherence and treatment outcomes during treatment of scalp psoriasis with Daivobet® gel Applicator for 4 weeks.

Enrollment: 1,560 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years
• Dermatologist or general practitioner has decided to initiate treatment with Daivobet® gel Applicator

Exclusion criteria

• Indication not within the approved labelling in France
• Contraindication for treatment with calcipotriol or betamethasone dipropionate
• Informed consent to participate in the study has not been obtained